Longevity Pharmaceuticals

Doxycycline (low-dose)

Research / preclinical

MMP modulator at sub-antibiotic dose — connective tissue, periodontal support.

Open in AppAsk AI Advisor

Mechanism

Sub-antibiotic dose MMP modulator. MMP modulator at sub-antibiotic dose — connective tissue, periodontal support. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.

Peer-Reviewed Studies (2)

Sub-antimicrobial Dose Doxycycline for Periodontitis

J Periodontol · 2003

20mg doxycycline reduced periodontal disease markers.

PubMed PMID 12715986 →

Doxycycline MMP Inhibition in Aortic Aneurysm

JAMA · 2002

Reduced AAA progression in early studies.

PubMed PMID 11926896 →

Related Compounds

Rapamycin

The only molecule shown to extend lifespan in every species tested — yeast to mammals.

Metformin

Most-prescribed diabetes drug, repurposed as the first FDA-approved aging trial.

Acarbose

Lifespan-extending diabetes drug — slows carb absorption, blunts post-meal glucose.

Low-Dose Naltrexone (LDN)

Off-label utility player — autoimmune modulation, pain reduction, HPA-axis support.

SGLT2 Inhibitors (Empagliflozin)

Diabetes drug with off-label longevity interest — cardiac, renal, metabolic benefits.

Telmisartan

ARB blood pressure med with PPARγ activity — investigational longevity application.